IC

DRUG3 trials

Sponsors

Alliance for Clinical Trials in Oncology, Universitair Ziekenhuis Brussel, Genmab

Conditions

Acute Renal FailureCO2 RemovalContinuous Renal Replacement TherapyEndometrial CancerEsophageal CancerNutrition PoorRecurrent or Progressive Endometrial Cancer

Phase 2

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

CompletedNCT00381706

Alliance for Clinical Trials in OncologyEsophageal Cancer

Start: 2006-09-15End: 2014-10-15Updated: 2021-09-29

Phase 3

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

RecruitingNCT07166094

GenmabEndometrial Cancer, Recurrent or Progressive Endometrial Cancer

Start: 2025-11-28End: 2029-11-01Target: 660Updated: 2026-05-06

Unknown Phase

Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry

CompletedNCT03314363

Universitair Ziekenhuis BrusselAcute Renal Failure, CO2 Removal, Continuous Renal Replacement Therapy +1

Start: 2017-04-26End: 2019-03-15Updated: 2022-05-18

Related Papers

CO2 and O2 removal during continuous veno-venous hemofiltration: a pilot study

BMC Nephrology2019-06-1721 citations